CEO Dr Michael Baker’s interview with JustStocks

MediaAll
Written By Michelle Long

Arovella CEO and Managing Director Michael Baker tells JustStocks Video the company achieved a critical milestone in the June quarter by completing process development to define a clinic-ready manufacturing process for ALA-101 and the CAR-iNKT cell platform.

 
Michelle Long
Previous

TechKnow Invest presentation
Next

Dr Michael Baker interviewed on ‘The Sub11 Podcast’